AI assistant
UroGen Pharma Ltd. — Director's Dealing 2025
Feb 4, 2025
32312_dirs_2025-02-04_bc23e643-478b-4b8c-a1d4-d7af335de863.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UroGen Pharma Ltd. (URGN)
CIK: 0001668243
Period of Report: 2025-01-31
Reporting Person: Schoenberg Mark (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-01-31 | Ordinary Shares | M | 1334 | — | Acquired | 146425 | Direct |
| 2025-01-31 | Ordinary Shares | S | 759 | $11.14 | Disposed | 145666 | Direct |
| 2025-01-31 | Ordinary Shares | M | 3333 | — | Acquired | 148999 | Direct |
| 2025-01-31 | Ordinary Shares | S | 1896 | $11.14 | Disposed | 147103 | Direct |
| 2025-01-31 | Ordinary Shares | M | 3333 | — | Acquired | 150436 | Direct |
| 2025-01-31 | Ordinary Shares | S | 1896 | $11.14 | Disposed | 148540 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-01-31 | Restricted Stock Units | $ | M | 1334 | Disposed | Ordinary Shares (1334) | Direct | |
| 2025-01-31 | Restricted Stock Units | $ | M | 3333 | Disposed | Ordinary Shares (3333) | Direct | |
| 2025-01-31 | Restricted Stock Units | $ | M | 3333 | Disposed | Ordinary Shares (3333) | Direct | |
| 2025-01-31 | Restricted Stock Units | $ | A | 20000 | Acquired | Ordinary Shares (20000) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
F2: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
F3: The reporting person was granted RSUs on January 31, 2022 representing 4,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023.
F4: The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024.
F5: The reporting person was granted RSUs on January 31, 2024 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025.
F6: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2026, January 31, 2027 and January 31, 2028.